Reasons for treatment discontinuation in the first year after beginning antiretroviral therapy in a cohort of Portuguese HIV-infected patients by Caldas, C et al.
POSTER PRESENTATION Open Access
Reasons for treatment discontinuation in the first
year after beginning antiretroviral therapy in a
cohort of Portuguese HIV-infected patients
C Caldas
*, P Andrade, C Azevedo, C Piñeiro, R Serrão, J Soares, R Marques, A Sarmento
From Tenth International Congress on Drug Therapy in HIV Infection
Glasgow, UK. 7-11 November 2010
Purpose of study
To evaluate the reasons and risk factors for antiretroviral
discontinuation in a cohort of HIV-infected patients in
the first year after starting combined antiretroviral ther-
apy (cART) for the first time.
Methods
A cohort of naïve HIV-infected patients who started
cART in the context of a national reimbursement pro-
gram from January 2007 onwards is being prospectively
followed. For each individual, the date and reason of the
first discontinuation of any drug in the initial regimen
was identified. Changes to same drug formulations were
not counted as discontinuations.
Results
399 patients were enrolled, with a mean follow-up of
82±48 weeks. This study concerns the 248 (62.2%)
patients who have a follow-up of ≥1 year. Mean age
42.2±12.3 years (range 78-20), 71.8% were males. 98.8%
were HIV-1-infected. HIV was sexually transmitted in
77.8% of the patients, 21.0% were IVDUs; in 1,2% risk
was undetermined. HCV/HBV co-infection respectively
in 24.6% and 4.4%. At baseline: 28.6% of the patients
had AIDS. Mean CD4 cell count 185 cells/mm
3 (range
2-833). Viral load (VL) >100000 copies/mL in 55.6%. The
cART regimen was based in NNRTIs /PIs in respectively
67.3% and 31.9% of the patients.
A total of 109 (44.0%) patients discontinued at least
one drug in their cART regimen. The main reasons for
discontinuation were: drug related adverse effects (39/
35.8%), lack of adherence/lost to follow up (20/18.3%),
virological failure (18/16.5%), regimen simplification (17/
15.6%), increased CV risk (7/6.4%), pregnancy (4/3.7%).
Four patients died. Low median CD4 count (p=0.021)
and high median viral load (p=0.075) were found to be
associated with virological failure.
Conclusions
Drug related adverse effects were the main cause of anti-
retroviral discontinuations in this cohort, with a rate
higher than the combined rates for lack of adherence/lost
to follow-up and virological failure. Continued attempts
to improve the tolerability of cART regimens and patient
adherence may help to minimize drug discontinuation
rates over the longer term.
Published: 8 November 2010
doi:10.1186/1758-2652-13-S4-P13
Cite this article as: Caldas et al.: Reasons for treatment discontinuation
in the first year after beginning antiretroviral therapy in a cohort of
Portuguese HIV-infected patients. Journal of the International AIDS Society
2010 13(Suppl 4):P13.
Hospital Sao Joao, Infectious Diseases, Porto, Portugal
Full list of author information is available at the end of the article
Caldas et al. Journal of the International AIDS Society 2010, 13(Suppl 4):P13
http://www.jiasociety.org/content/13/S4/P13
© 2010 Caldas et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.